Oral Orforglipron Yields Greater Weight Reductions Than Placebo

THURSDAY, Sept. 25, 2025 (HealthDay News) -- For adults with obesity who do not have diabetes, the oral glucagon-like peptide-1 receptor agonist orforglipron yi